ArticleBritish journal of cancer2015

Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.

Y Horimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.